Overview

[99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression

Status:
ENROLLING_BY_INVITATION

Trial end date:
2026-12-31

Target enrollment:

Participant gender:

Summary

The study should evaluate the \[99mTc\]Tc-DB8 accumulation in primary tumour of breast cancer patients with positive and negative estrogen receptor expression

Phase:

PHASE2

Details

Lead Sponsor:

Tomsk National Research Medical Center of the Russian Academy of Sciences

Collaborator:

Uppsala University